arrow
N

Nikhil Patkar

Advanced Centre for Treatment
H指数:21
被引数:5,273

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Attrition Rates in Multiple Myeloma - A Report from indian Patients at A Tertiary Cancer Center

多发性骨髓瘤患者的流失率——来自印度某三级癌症中心的患者报告

2025-12-010
OAAI
Treatment free remission (TFR) in chronic myeloid leukemia—results, compliance and patterns of failure from a tertiary care cancer centre in India

慢性髓性白血病中的无治疗缓解(TFR)——来自印度一家三级护理癌症中心的结果、依从性及失败模式

2025-10-310
OA
Prevalence and Prognostic Impact of NPM1 mutation in Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Cancer Centre in India

NPM1突变在儿童急性髓系白血病中的患病率及预后影响:来自印度一家三级癌症中心的经验

2025-10-210
PRE
Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study (vol 15, 75, 2025)

新型人源化CD19-CAR-T(现名为talicabtagene autoleucel,Tali-cel™)细胞在复发/难治性儿童B急性淋巴细胞白血病中的应用——一项开放标签单臂I/Ib期研究(卷15,第75期,2025年)

2025-05-200
OA
Treatment-Free Remissions in Children With Chronic Myeloid Leukemia (CML): A Prospective Study From the Tata Memorial Hospital (TMH) Pediatric CML (pCML) Cohort

慢性粒细胞白血病 (CML) 儿童的无治疗缓解: 来自塔塔纪念医院 (TMH) 儿科CML (pCML) 队列的前瞻性研究

2024-11-200
OAAI
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant
2024-04-010
OAAI
Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) - experience from Tata Memorial Hospital, India
2023-07-210
PRE
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

世界卫生组织第5版血淋巴肿瘤分类: 骨髓和组织细胞/树突状肿瘤

LEUKEMIA
IF13.4
2022-06-221.8K
OAAI
Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin's Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India
2022-03-019
OAAI
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients
2021-10-278
OAAI
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)
LEUKEMIA
IF13.4
2021-02-0864
OAAI